Trial intelligence / Profile preview

Topical ketamine for pain relief during venipuncture

IRCT20180129038549N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of ketamine in acute pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain severity during venipuncture. Started Oct 2017; status: completed.

02

Drugs

ketamine
03

Conditions

acute pain

Beyond the preview

Go deeper on IRCT20180129038549N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180129038549N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call